Copyright
©The Author(s) 2025.
World J Diabetes. Feb 15, 2025; 16(2): 98423
Published online Feb 15, 2025. doi: 10.4239/wjd.v16.i2.98423
Published online Feb 15, 2025. doi: 10.4239/wjd.v16.i2.98423
Figure 1 The rates of negative (grey), weakly (blue), moderately (yellow), and strongly positive (red) Ki-67 expression in the three groups.
A: Patients with acute ischemic stroke (AIS) and type 2 diabetes mellitus; B: Patients with AIS alone; C: Patients with benign pulmonary lesions.
- Citation: Chen K, Wang G, Hu JC, Zhou YY, Ma HT. Clinical significance of Ki-67 in patients with lung adenocarcinoma in situ complicated by type 2 diabetes. World J Diabetes 2025; 16(2): 98423
- URL: https://www.wjgnet.com/1948-9358/full/v16/i2/98423.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i2.98423